WEZENLA
As listed in the register: WEZENLA 130 mg, solution à diluer pour perfusion
130 mg · solution à diluer pour perfusion
- Prescription only
- Active substance
- Ustékinumab
- Made by
- AMGEN TECHNOLOGY (IRELAND)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | AMGEN TECHNOLOGY (IRELAND) |
|---|---|
| Active substance | Ustékinumab |
| Strength | 130 mg |
| Form | solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · prescription réservée aux spécialistes et services HEPATO/GASTRO-ENTEROLOGIE · prescription réservée aux spécialistes et services MEDECINE INTERNE · liste I |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/24/1823 |
| Name in the register | WEZENLA 130 mg, solution à diluer pour perfusion |
| Packs | 1 flacon en verre de 26 mL |
| CIS | 61183445 |
| CIP13 | 3400955101918 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution injectable5 products
45 mg3
90 mg2
90 mg · 2 companies
- solution à diluer pour perfusion1 products
- 130 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.